ELAN
HOLD / NEUTRALMeanRevComposite
57.60
Technical
56.00
Fundamental
58.20
Rank
—
Price
24.42
Hurst
0.28
As of
Aug 25, 2026
Daily
Elanco Animal Health Incorporated
HealthcareDrug Manufacturers - Specialty & GenericElanco Animal Health develops and sells medications and vaccines for companion animals and livestock across global markets. For pets, the company produces flea and tick prevention products, vaccines, and treatments for conditions including pain, ear infections, and skin diseases. For farm animals such as cattle, poultry, and swine, Elanco offers feed additives, antibiotics, vaccines, and products to prevent intestinal disease and improve overall herd health. The company distributes its products through veterinarians, farm producers, distributors, and retailers.
Market cap
$11.4B
P/E (trailing)
—
P/E (forward)
17.68
PEG ratio
4.04
Dividend yield
—
Beta
1.68
52w range
18.48 – 27.98
Return on equity
-2.98%
Profit margin
-3.96%
Revenue growth
+10.20%
Earnings growth
+440.50%
Price history
1Y: 22.74 (+19.1%) · range 18.54–26.84
Cycle position
41/ 100 cycle scoreAPPROACHING ENTRY
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT
entry readiness 41 · WEAK SETUP · exit proximity 0
Conviction
32/ 100 · maturity 100%
VScore.4013
Buildup.2037
EMA entry setup.2541
Fundamentals.1558
Volume profile
POC
24.12
Price vs POC
-5.7%
Overhead supply
76%
Runway
+2.3%
Value area 22.15–25.23 · 76% of 120d volume overhead · heavy supply
Contributing sources
| Source | Score | Last seen |
|---|---|---|
| short-interest | 0.327 | Aug 31, 2026 |
| squeeze-risk | 0.213 | Aug 31, 2026 |
| earnings-surprise | 0.033 | Sep 3, 2026 |
Forward returns
| Horizon | Return | MFE | State |
|---|---|---|---|
| 20d | -7.65% | -0.04% | 12/20d |
| 40d | -7.65% | -0.04% | 12/40d |